The Manga Club rallies around a devastated Aria after she breaks the news. Fortunately, Okumura can’t help but feel there’s more to the story than what Aria overheard. Our Take(Spoilers): I was hoping ...

According to Securities Star news, data from the Tianyancha APP shows that Gree Electric Appliances (000651) has recently obtained authorization for an invention patent titled 'Control Method, Device, ...

Tencent Kona SM Suite is a set of Java security providers, which service the ShangMi applications in Java ecosystem. This suite contains six providers: Tencent Kona SM Suite supports all the JDK ...

Abstract: Phased array antennas are essential for Earth observation and target tracking, with dual utility in both civilian and military applications. In line with the growing demand for ...

DUNCAN, S.C. (WCBD) — Gov. Henry McMaster (R) is set to provide an update Wednesday on a program that helps get school resource officers placed in districts across the state. McMaster is scheduled to ...

Amylyx’s withdrawn-from-market Relyvrio has failed to make an impact on primary or secondary endpoints in a rare neurodegenerative disease, prompting the company to discontinue the program. Oral ...

BRANFORD, Conn., Aug. 27, 2025 /PRNewswire/ -- Azitra, Inc. ("Azitra") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision ...

A federal-state partnership that monitors for foodborne illnesses quietly scaled back its operations nearly two months ago. As of July 1, the Foodborne Diseases Active Surveillance Network (FoodNet) ...

Apple is reportedly developing the Studio Display 2, a successor to its original Studio Display, with a focus on addressing previous shortcomings and introducing meaningful upgrades. Expected to ...

Abstract: To generate high-power, high-directivity terahertz (THz) radiation, in this article, we propose and fabricate a 2-D resonant-tunneling-diode (RTD) THz oscillator array. The array is formed ...

AbbVie has written the next chapter in its epic quest to treat psychiatric disorders, agreeing to buy a psychedelic drug candidate from Gilgamesh Pharmaceuticals for up to $1.2 billion. Bloomberg ...